Cost comparison of a once-daily parenteral antibiotic in hospital settings: Information from the sidestep study

被引：0
|
作者：
Turpin, RS
Tice, A
Wu, JH
Taylor, S
Polis, A
Abramson, M
机构：
[1] Merck & Co Inc, West Point, PA USA
[2] Univ Hawaii, Honolulu, HI 96822 USA
来源：
VALUE IN HEALTH | 2006年 / 9卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)64779-1
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A153 / A154
页数：2
相关论文
共 50 条
  • [21] COMPARISON OF THE EFFICACY AND SAFETY OF ONCE-DAILY GLYCOPYRRONIUM WITH BLINDED TIOTROPIUM IN PATIENTS WITH COPD: THE GLOW5 STUDY
    Chapman, Kenneth R.
    Beeh, Kai
    Bateman, Eric D.
    Beier, Jutta
    D'Urzo, Anthony
    Nutbrown, Robert
    Chen, Hungta
    Henley, Michelle
    Overend, Tim
    D'Andrea, Peter
    RESPIROLOGY, 2013, 18 : 30 - 30
  • [22] COST-EFFECTIVENESS OF ONCE-DAILY SOMATROPIN FROM SANDOZ VERSUS ONCE-WEEKLY SOMATROGON FOR THE TREATMENT OF GROWTH HORMONE DEFICIENCY IN CHILDREN AND ADOLESCENTS
    Mehl, A.
    Goh, A.
    Gupts, S.
    VALUE IN HEALTH, 2022, 25 (12) : S171 - S171
  • [23] Conversion from twice- to once-daily tacrolimus in pediatric kidney recipients: a pharmacokinetic and bioequivalence study
    Lapeyraque, Anne-Laure
    Kassir, Nastya
    Theoret, Yves
    Krajinovic, Maja
    Clermont, Marie-Jose
    Litalien, Catherine
    Phan, Veronique
    PEDIATRIC NEPHROLOGY, 2014, 29 (06) : 1081 - 1088
  • [24] Conversion from twice- to once-daily tacrolimus in pediatric kidney recipients: a pharmacokinetic and bioequivalence study
    Anne-Laure Lapeyraque
    Nastya Kassir
    Yves Théorêt
    Maja Krajinovic
    Marie-José Clermont
    Catherine Litalien
    Véronique Phan
    Pediatric Nephrology, 2014, 29 : 1081 - 1088
  • [25] A NOVEL STUDY DESIGN FOR THE COMPARISON BETWEEN ONCE-DAILY QVA149 AND TWICE-DAILY SALMETEROL/FLUTICASONE ON THE REDUCTION OF COPD EXACERBATIONS: THE FLAME STUDY
    Kwaijtaal, M.
    Wedzicha, J.
    Decramer, M.
    Vestbo, J.
    Banerji, D.
    RESPIROLOGY, 2014, 19 : 117 - 117
  • [26] GUIDE study: double-blind comparison of once-daily gliclazide MR and glimepiride in type 2 diabetic patients
    Schernthaner, G
    Grimaldi, A
    Di Mario, U
    Drzewoski, J
    Kempler, P
    Kvapil, M
    Novials, A
    Rottiers, R
    Rutten, GEHM
    Shaw, KM
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2004, 34 (08) : 535 - 542
  • [27] A Novel Study Design for the Comparison Between Once-Daily QVA149 and Twice-Daily Salmeterol/Fluticasone on the Reduction of COPD Exacerbations: The FLAME Study
    Wedzicha, Jadwiga
    Vestbo, Jorgen
    Gallagher, Nicola
    Banerji, Donald
    CHEST, 2014, 145 (03)
  • [28] A novel study design for the comparison between once-daily QVA149 and twice-daily salmeterol/fluticasone on the reduction of COPD exacerbations: The FLAME study
    Wedzicha, Jadwiga A.
    Decramer, Marc
    Vestbo, Jorgen
    Gallagher, Nicola
    Kim, Han-Joo
    McBryan, Danny
    Banerji, Donald
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [29] Comparison of once-daily versus twice-weekly terbinafine administration for the treatment of canine Malassezia dermatitis - a pilot study
    Berger, Darren J.
    Lewis, Thomas P.
    Schick, Anthea E.
    Stone, Richard T.
    VETERINARY DERMATOLOGY, 2012, 23 (05)
  • [30] ONCE-DAILY CONTROL OF PANIC DISORDER - EVIDENCE FROM A PLACEBO-CONTROLLED STUDY OF ALPRAZOLAM-XR
    SCHWEIZER, E
    PSYCHIATRIC ANNALS, 1993, : 32 - 37
12345